A 16-year-female presented with history of irregular fever of five-month duration and left upper quadrant pain. She had moderate pallor, mild hepatomegaly and massive splenomegaly. Hemogram showed pancytopenia (hemoglobin-71 gm/L, total leucocyte count-2.0 × 109/L and platelet count-34 × 109/L). Peripheral blood film showed normal differential leukocyte counts with presence of nucleated red cells. Clinical, bone marrow (Fig. 1a–c), immunophenotypic findings (Fig. 1d–i) and T cell receptor gamma gene re-arrangement assay (Fig. 2a) were consistent with a diagnosis of hepatosplenic T cell lymphoma of gamma-delta T cell receptor type (γδHSTL). Fluorescence in-situ hybridization (FISH) testing showed 5–7 copies of 7q31 and two copies of centromere 7 consistent with amplification of 7q31 locus (Fig. 2b). Patient received 3 cycles of CHOP (Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone) therapy till last follow up. Patient responded well with improvement in symptoms and hemogram findings (hemoglobin-139 g/L, leukocyte count-6.5 × 109/L and platelet count-83.0 × 109/L). Amplification of 7q22-q31 results from either isochromosome 7q [(i7)(q10)] or ring 7 (r7) [1]; and results in not only the gain of several putative cancer genes in 7q22-31 region, but also loss of genes in 7p favouring tumour growth [2]. While, (i7)(q10) and r(7) are hall mark findings identified by karyotyping in γδHSTL, the demonstration of amplification of 7q31 by a dual-colour FISH is an alternative cost-effective method to establish the diagnosis in patients with a diagnostic dilemma with closely related differential diagnoses including T-lineage acute lymphoblastic leukaemia-γδ type.
Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.